The 4 most recent market catalysts affecting $OSRH, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 3, 2026
Corporate Catalyst
Neutral
Impact 85
OSR Health Board Authorizes Management to Engage with Potential Acquirer of OSRK for Reverse Takeover
OSR Health's board has greenlit exploring a reverse takeover, where it would sell its 84.5% stake in OSRK to an unnamed Nasdaq-listed company in exchange for stock. This strategic …
Oct 30, 2026
Corporate Catalyst
Bullish
Impact 65
OSR Health Provides Update Following Nasdaq Delisting Decision
OSR Health has been delisted from Nasdaq due to its failure to maintain the $1.00 minimum bid price, a significant blow to its public market standing. The company is now trading on…
Aug 19, 2026
Corporate Catalyst
Bearish
Impact 85
OSR Health Says It Plans To Request Panel Hearing After Receiving Nasdaq Delisting Determination; Common Stock And Warrants To Be Suspended August 26
The delisting determination for OSR Health is a major negative corporate catalyst. It implies the company has failed to meet Nasdaq's listing requirements, often related to financi…
Aug 19, 2026
Corporate Catalyst
Neutral
Impact 55
OSR Health Issues CEO Letter To Shareholders Addressing Extraordinary Trading Activity, Global Shareholder Support, Nasdaq Compliance And CVR Program
OSR Health's CEO released a letter to shareholders to address several pressing issues, including unusual trading activity, ongoing efforts to maintain Nasdaq compliance, and update…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.